Andrade Robert has filed 59 insider transactions across 1 company since March 2023.
Most recent transaction: a option exercise of 2213 shares of FENNEC PHARMACEUTICALS INC. ($FENC) on March 31, 2026.
Activity breakdown: 1 open-market purchase and 7 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 31, 2026 | FENNEC PHARMACEUTICALS INC. | $FENC | Andrade Robert | CHIEF FINANCIAL OFFICER | M | Common shares | 2213 | $0.00 | 273,593.0000 | 28,577,000 | 0.82% | 0.01% |
| March 31, 2026 | FENNEC PHARMACEUTICALS INC. | $FENC | Andrade Robert | CHIEF FINANCIAL OFFICER | M | Common shares | 14724 | $0.00 | 271,380.0000 | 28,577,000 | 5.74% | 0.05% |
| March 31, 2026 | FENNEC PHARMACEUTICALS INC. | $FENC | Andrade Robert | CHIEF FINANCIAL OFFICER | A | Stock Options | 120000 | $5.77 | 921,045.0000 | 28,577,000 | 14.98% | 0.42% |
| March 28, 2026 | FENNEC PHARMACEUTICALS INC. | $FENC | Andrade Robert | CHIEF FINANCIAL OFFICER | M | Common shares | 12270 | $0.00 | 285,863.0000 | 28,577,000 | 4.48% | 0.04% |
| March 26, 2026 | FENNEC PHARMACEUTICALS INC. | $FENC | Andrade Robert | CHIEF FINANCIAL OFFICER | M | Common shares | 13072 | $5.10 | 256,656.0000 | 27,889,000 | 5.37% | 0.05% |
| March 26, 2026 | FENNEC PHARMACEUTICALS INC. | $FENC | Andrade Robert | CHIEF FINANCIAL OFFICER | M | Stock Options | 13072 | $5.10 | 801,045.0000 | 27,889,000 | 1.61% | 0.05% |
| Feb. 28, 2026 | FENNEC PHARMACEUTICALS INC. | $FENC | Andrade Robert | CHIEF FINANCIAL OFFICER | A | Common shares | 1191 | $0.00 | 243,584.0000 | 27,889,000 | 0.49% | 0.00% |
| Feb. 18, 2026 | FENNEC PHARMACEUTICALS INC. | $FENC | Andrade Robert | CHIEF FINANCIAL OFFICER | M | Common shares | 27285 | $0.00 | 242,393.0000 | 27,889,000 | 12.68% | 0.10% |
| Feb. 18, 2026 | FENNEC PHARMACEUTICALS INC. | $FENC | Andrade Robert | CHIEF FINANCIAL OFFICER | M | Stock Options | 2450 | $4.08 | 814,117.0000 | 27,889,000 | 0.30% | 0.01% |
| Feb. 18, 2026 | FENNEC PHARMACEUTICALS INC. | $FENC | Andrade Robert | CHIEF FINANCIAL OFFICER | M | Common shares | 2450 | $4.08 | 215,108.0000 | 27,889,000 | 1.15% | 0.01% |
| Jan. 31, 2026 | FENNEC PHARMACEUTICALS INC. | $FENC | Andrade Robert | CHIEF FINANCIAL OFFICER | A | Common shares | 1558 | $0.00 | 212,658.0000 | 27,889,000 | 0.74% | 0.01% |
| Jan. 23, 2026 | FENNEC PHARMACEUTICALS INC. | $FENC | Andrade Robert | CHIEF FINANCIAL OFFICER | M | Stock Options | 10000 | $2.45 | 816,567.0000 | 27,889,000 | 1.21% | 0.04% |
| Jan. 23, 2026 | FENNEC PHARMACEUTICALS INC. | $FENC | Andrade Robert | CHIEF FINANCIAL OFFICER | M | Common shares | 10000 | $2.45 | 211,100.0000 | 27,889,000 | 4.97% | 0.04% |
| Jan. 15, 2026 | FENNEC PHARMACEUTICALS INC. | $FENC | Andrade Robert | CHIEF FINANCIAL OFFICER | M | Common shares | 10000 | $2.45 | 201,100.0000 | 27,889,000 | 5.23% | 0.04% |
| Jan. 15, 2026 | FENNEC PHARMACEUTICALS INC. | $FENC | Andrade Robert | CHIEF FINANCIAL OFFICER | M | Stock Options | 10000 | $2.45 | 826,567.0000 | 27,889,000 | 1.20% | 0.04% |
| Jan. 7, 2026 | FENNEC PHARMACEUTICALS INC. | $FENC | Andrade Robert | CHIEF FINANCIAL OFFICER | M | Stock Options | 14184 | $2.45 | 836,567.0000 | 27,889,000 | 1.67% | 0.05% |
| Jan. 7, 2026 | FENNEC PHARMACEUTICALS INC. | $FENC | Andrade Robert | CHIEF FINANCIAL OFFICER | M | Common shares | 14184 | $2.45 | 191,100.0000 | 27,889,000 | 8.02% | 0.05% |
| Dec. 31, 2025 | FENNEC PHARMACEUTICALS INC. | $FENC | Andrade Robert | CHIEF FINANCIAL OFFICER | A | Common shares | 1382 | $0.00 | 176,916.0000 | 27,889,000 | 0.79% | 0.00% |
| Dec. 1, 2025 | FENNEC PHARMACEUTICALS INC. | $FENC | Andrade Robert | CHIEF FINANCIAL OFFICER | A | Common shares | 2430 | $0.00 | 175,534.0000 | 27,889,000 | 1.40% | 0.01% |
| Oct. 31, 2025 | FENNEC PHARMACEUTICALS INC. | $FENC | Andrade Robert | CHIEF FINANCIAL OFFICER | A | Common shares | 2430 | $0.00 | 173,104.0000 | 27,889,000 | 1.42% | 0.01% |
| Sept. 30, 2025 | FENNEC PHARMACEUTICALS INC. | $FENC | Andrade Robert | CHIEF FINANCIAL OFFICER | A | Common shares | 2430 | $0.00 | 170,674.0000 | 27,664,000 | 1.44% | 0.01% |
| Aug. 31, 2025 | FENNEC PHARMACEUTICALS INC. | $FENC | Andrade Robert | CHIEF FINANCIAL OFFICER | A | Common shares | 2431 | $0.00 | 168,244.0000 | 27,664,000 | 1.47% | 0.01% |
| July 31, 2025 | FENNEC PHARMACEUTICALS INC. | $FENC | Andrade Robert | CHIEF FINANCIAL OFFICER | A | Common shares | 2431 | $0.00 | 165,813.0000 | 27,664,000 | 1.49% | 0.01% |
| June 30, 2025 | FENNEC PHARMACEUTICALS INC. | $FENC | Andrade Robert | CHIEF FINANCIAL OFFICER | A | Common shares | 2431 | $0.00 | 163,382.0000 | 27,578,000 | 1.51% | 0.01% |
| May 31, 2025 | FENNEC PHARMACEUTICALS INC. | $FENC | Andrade Robert | CHIEF FINANCIAL OFFICER | A | Common shares | 2431 | $0.00 | 160,951.0000 | 27,578,000 | 1.53% | 0.01% |
| May 22, 2025 | FENNEC PHARMACEUTICALS INC. | $FENC | Andrade Robert | CHIEF FINANCIAL OFFICER | M | Stock Options | 8220 | $5.10 | 850,751.0000 | 27,578,000 | 0.96% | 0.03% |
| May 22, 2025 | FENNEC PHARMACEUTICALS INC. | $FENC | Andrade Robert | CHIEF FINANCIAL OFFICER | M | Common shares | 8220 | $5.10 | 158,520.0000 | 27,578,000 | 5.47% | 0.03% |
| May 16, 2025 | FENNEC PHARMACEUTICALS INC. | $FENC | Andrade Robert | CHIEF FINANCIAL OFFICER | A | Common shares | 16667 | $0.00 | 150,300.0000 | 27,578,000 | 12.47% | 0.06% |
| April 30, 2025 | FENNEC PHARMACEUTICALS INC. | $FENC | Andrade Robert | CHIEF FINANCIAL OFFICER | A | Common shares | 1042 | $0.00 | 133,633.0000 | 27,578,000 | 0.79% | 0.00% |
| March 28, 2025 | FENNEC PHARMACEUTICALS INC. | $FENC | Andrade Robert | CHIEF FINANCIAL OFFICER | A | Restricted Share Unit | 75000 | $0.00 | 827,722.0000 | 27,294,000 | 9.96% | 0.27% |
| March 28, 2025 | FENNEC PHARMACEUTICALS INC. | $FENC | Andrade Robert | CHIEF FINANCIAL OFFICER | A | Stock Options | 50000 | $0.00 | 877,722.0000 | 27,294,000 | 6.04% | 0.18% |
| March 31, 2025 | FENNEC PHARMACEUTICALS INC. | $FENC | Andrade Robert | CHIEF FINANCIAL OFFICER | A | Common shares | 1042 | $0.00 | 132,591.0000 | 27,294,000 | 0.79% | 0.00% |
| Feb. 28, 2025 | FENNEC PHARMACEUTICALS INC. | $FENC | Andrade Robert | CHIEF FINANCIAL OFFICER | A | Common shares | 1042 | $0.00 | 131,549.0000 | 27,294,000 | 0.80% | 0.00% |
| Jan. 31, 2025 | FENNEC PHARMACEUTICALS INC. | $FENC | Andrade Robert | CHIEF FINANCIAL OFFICER | A | Common shares | 1042 | $0.00 | 130,507.0000 | 27,294,000 | 0.80% | 0.00% |
| Dec. 31, 2024 | FENNEC PHARMACEUTICALS INC. | $FENC | Andrade Robert | CHIEF FINANCIAL OFFICER | A | Common shares | 1042 | $0.00 | 129,465.0000 | 27,371,000 | 0.81% | 0.00% |
| Dec. 2, 2024 | FENNEC PHARMACEUTICALS INC. | $FENC | Andrade Robert | CHIEF FINANCIAL OFFICER | A | Common shares | 1042 | $0.00 | 128,423.0000 | 27,371,000 | 0.82% | 0.00% |
| Nov. 18, 2024 | FENNEC PHARMACEUTICALS INC. | $FENC | Andrade Robert | CHIEF FINANCIAL OFFICER | M | Common shares | 15816 | $2.45 | 127,381.0000 | 27,371,000 | 14.18% | 0.06% |
| Nov. 18, 2024 | FENNEC PHARMACEUTICALS INC. | $FENC | Andrade Robert | CHIEF FINANCIAL OFFICER | M | Stock Options | 15816 | $2.45 | 689,184.0000 | 27,371,000 | 2.24% | 0.06% |
| Oct. 31, 2024 | FENNEC PHARMACEUTICALS INC. | $FENC | Andrade Robert | CHIEF FINANCIAL OFFICER | A | Common shares | 1042 | $0.00 | 111,565.0000 | 27,371,000 | 0.94% | 0.00% |
| Sept. 30, 2024 | FENNEC PHARMACEUTICALS INC. | $FENC | Andrade Robert | CHIEF FINANCIAL OFFICER | A | Common shares | 1042 | $0.00 | 110,523.0000 | 27,297,000 | 0.95% | 0.00% |
| Aug. 31, 2024 | FENNEC PHARMACEUTICALS INC. | $FENC | Andrade Robert | CHIEF FINANCIAL OFFICER | A | Common shares | 1042 | $0.00 | 109,481.0000 | 27,297,000 | 0.96% | 0.00% |
| July 31, 2024 | FENNEC PHARMACEUTICALS INC. | $FENC | Andrade Robert | CHIEF FINANCIAL OFFICER | A | Common shares | 1042 | $0.00 | 108,439.0000 | 27,297,000 | 0.97% | 0.00% |
| July 1, 2024 | FENNEC PHARMACEUTICALS INC. | $FENC | Andrade Robert | CHIEF FINANCIAL OFFICER | A | Common shares | 1042 | $0.00 | 107,397.0000 | 27,297,000 | 0.98% | 0.00% |
| May 31, 2024 | FENNEC PHARMACEUTICALS INC. | $FENC | Andrade Robert | CHIEF FINANCIAL OFFICER | A | Common shares | 1042 | $0.00 | 106,355.0000 | 31,091,000 | 0.99% | 0.00% |
| May 16, 2024 | FENNEC PHARMACEUTICALS INC. | $FENC | Andrade Robert | CHIEF FINANCIAL OFFICER | A | Stock Option (right to buy) | 100000 | $0.00 | 728,958.0000 | 31,091,000 | 15.90% | 0.32% |
| May 16, 2024 | FENNEC PHARMACEUTICALS INC. | $FENC | Andrade Robert | CHIEF FINANCIAL OFFICER | A | Restricted Share Unit (right to receive value of a share) | 50000 | $0.00 | 778,958.0000 | 31,091,000 | 6.86% | 0.16% |
| April 30, 2024 | FENNEC PHARMACEUTICALS INC. | $FENC | Andrade Robert | CHIEF FINANCIAL OFFICER | A | Common shares | 1042 | $0.00 | 105,313.0000 | 31,091,000 | 1.00% | 0.00% |
| April 1, 2024 | FENNEC PHARMACEUTICALS INC. | $FENC | Andrade Robert | CHIEF FINANCIAL OFFICER | P | Common shares | 12500 | $0.00 | 104,271.0000 | 31,091,000 | 13.62% | 0.04% |
| March 26, 2024 | FENNEC PHARMACEUTICALS INC. | $FENC | Andrade Robert | CHIEF FINANCIAL OFFICER | S | Common shares | 13975 | $10.90 | 91,771.0000 | 26,574,000 | 13.22% | 0.05% |
| March 25, 2024 | FENNEC PHARMACEUTICALS INC. | $FENC | Andrade Robert | CHIEF FINANCIAL OFFICER | S | Common shares | 13975 | $11.00 | 105,746.0000 | 26,574,000 | 11.67% | 0.05% |
| Jan. 5, 2024 | FENNEC PHARMACEUTICALS INC. | $FENC | Andrade Robert | CHIEF FINANCIAL OFFICER | S | Common shares | 15000 | $10.41 | 119,721.0000 | 26,574,000 | 11.13% | 0.06% |
| Jan. 4, 2024 | FENNEC PHARMACEUTICALS INC. | $FENC | Andrade Robert | CHIEF FINANCIAL OFFICER | S | Common shares | 15000 | $10.64 | 134,721.0000 | 26,574,000 | 10.02% | 0.06% |
| June 30, 2023 | FENNEC PHARMACEUTICALS INC. | $FENC | Andrade Robert | CHIEF FINANCIAL OFFICER | S | Common shares | 7500 | $8.82 | 124,721.0000 | 26,559,000 | 5.67% | 0.03% |
| June 30, 2023 | FENNEC PHARMACEUTICALS INC. | $FENC | Andrade Robert | CHIEF FINANCIAL OFFICER | M | Common Shares | 25000 | $2.45 | 605,000.0000 | 26,559,000 | 3.97% | 0.09% |
| June 30, 2023 | FENNEC PHARMACEUTICALS INC. | $FENC | Andrade Robert | CHIEF FINANCIAL OFFICER | M | Common shares | 25000 | $2.45 | 149,721.0000 | 26,559,000 | 20.04% | 0.09% |
| June 29, 2023 | FENNEC PHARMACEUTICALS INC. | $FENC | Andrade Robert | CHIEF FINANCIAL OFFICER | S | Common shares | 7500 | $8.97 | 132,221.0000 | 26,559,000 | 5.37% | 0.03% |
| June 28, 2023 | FENNEC PHARMACEUTICALS INC. | $FENC | Andrade Robert | CHIEF FINANCIAL OFFICER | S | Common shares | 10000 | $8.99 | 139,721.0000 | 26,559,000 | 6.68% | 0.04% |
| March 31, 2023 | FENNEC PHARMACEUTICALS INC. | $FENC | Andrade Robert | CHIEF FINANCIAL OFFICER | A | Stock Option (right to buy) | 75000 | $0.00 | 630,000.0000 | 26,275,000 | 13.51% | 0.29% |
| March 31, 2023 | FENNEC PHARMACEUTICALS INC. | $FENC | Andrade Robert | CHIEF FINANCIAL OFFICER | A | Restricted Share Unit (right to receive value of a share) | 37500 | $0.00 | 667,500.0000 | 26,275,000 | 5.95% | 0.14% |